Replies to post #31 on ImmunoPrecise Antibodies Ltd (IPA)

[Simbeez]

I have to agree with you on lack of shares available. Will be a clear case of supply and demand. 1. Price will go through the roof. 2. Large financing deal with one of the institutions. A couple of houses that IPA had deals with previously got into the buying big time in the past weeks, namely Haywood Securities and Cormack. These houses have an insight into IPA as they did the deals before and if they are buying then that's another good sign of things to come. Also, the last major financing in 2018 has 9.1 Million warrants that expire in Sept. 2020, priced at $1.25. This alone will bring over $11 Million into the company's coffers. We have almost reached that threshold for conversions to start happening. As well, there are other previous financing's which have more warrants still o/s. You could see them here if not already done so:
https://tmxmatrix.com/company/IPA/financings

I am really looking forward to the next few weeks / months. Thanks for the article you shared. IPA has the know how and combined with AI it just makes them that much better. As well combination of the all the animal mAB Therapeutics just speeds up the game that much faster.

I am an optimistic, believe in IPA. This is their time to come to the plate and hit the home run.